Advocacy for outpatient cardiac rehabilitation globally

Abraham Samuel Babu, Francisco Lopez-Jimenez, Randal J. Thomas, Wanrudee Isaranuwatchai, Artur Haddad Herdy, Jeffrey S. Hoch, Sherry L. Grace

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Background: Cardiovascular diseases (CVD) are the leading cause of death globally. Cardiac rehabilitation (CR) is an evidence-based intervention recommended for patients with CVD, to prevent recurrent events and to improve quality of life. However, despite the proven benefits, only a small percentage of those would benefit from CR actually receive it worldwide. This paper by the International Council of Cardiovascular Prevention and Rehabilitation forwards the groundwork for successful CR advocacy to achieve broader reimbursement, and hence implementation. Methods: First, the results of the International Council's survey on national CR reimbursement policies by government and insurance companies are summarized. Second, a multi-faceted approach to CR advocacy is forwarded. Finally, as per the advocacy recommendations, the economic impact of CVD and the corresponding benefits of CR and its cost-effectiveness are summarized. This provides the case for CR reimbursement advocacy. Results: Thirty-one responses were received, from 25 different countries: 18 (58.1 %) were from high-income countries, 10 (32.4 %) from upper middle-income, and 3 (9.9 %) from lower middle-income countries. When asked who reimburses at least some portion of CR services in their country, 19 (61.3 %) reported the government, 17 (54.8 %) reported patients pay out-of-pocket, 16 (51.6 %) reported insurance companies, 12 (38.7 %) reported that it is shared between the patient and another source, and 7 (22.6 %) reported another source. Conclusions: Many patients pay out-of-pocket for CR. CR reimbursement around the world is inconsistent and insufficient. Advocacy campaigns forwarding the CR cause, supported by the relevant literature, enlisting sources of support in a unified manner with an organized plan, are needed, and must be pursued persistently.

Original languageEnglish (US)
Article number417
JournalBMC Health Services Research
Volume16
Issue number1
DOIs
StatePublished - Sep 6 2016

Fingerprint

Outpatients
Cardiovascular Diseases
Insurance
Cardiac Rehabilitation
Cost-Benefit Analysis
Cause of Death
Economics
Quality of Life

Keywords

  • Cardiac rehabilitation
  • Cardiovascular disease
  • Insurance
  • Reimbursement

ASJC Scopus subject areas

  • Health Policy

Cite this

Babu, A. S., Lopez-Jimenez, F., Thomas, R. J., Isaranuwatchai, W., Herdy, A. H., Hoch, J. S., & Grace, S. L. (2016). Advocacy for outpatient cardiac rehabilitation globally. BMC Health Services Research, 16(1), [417]. https://doi.org/10.1186/s12913-016-1658-1

Advocacy for outpatient cardiac rehabilitation globally. / Babu, Abraham Samuel; Lopez-Jimenez, Francisco; Thomas, Randal J.; Isaranuwatchai, Wanrudee; Herdy, Artur Haddad; Hoch, Jeffrey S.; Grace, Sherry L.

In: BMC Health Services Research, Vol. 16, No. 1, 417, 06.09.2016.

Research output: Contribution to journalReview article

Babu, AS, Lopez-Jimenez, F, Thomas, RJ, Isaranuwatchai, W, Herdy, AH, Hoch, JS & Grace, SL 2016, 'Advocacy for outpatient cardiac rehabilitation globally', BMC Health Services Research, vol. 16, no. 1, 417. https://doi.org/10.1186/s12913-016-1658-1
Babu, Abraham Samuel ; Lopez-Jimenez, Francisco ; Thomas, Randal J. ; Isaranuwatchai, Wanrudee ; Herdy, Artur Haddad ; Hoch, Jeffrey S. ; Grace, Sherry L. / Advocacy for outpatient cardiac rehabilitation globally. In: BMC Health Services Research. 2016 ; Vol. 16, No. 1.
@article{e52d68a987d04324acdf6036489f7104,
title = "Advocacy for outpatient cardiac rehabilitation globally",
abstract = "Background: Cardiovascular diseases (CVD) are the leading cause of death globally. Cardiac rehabilitation (CR) is an evidence-based intervention recommended for patients with CVD, to prevent recurrent events and to improve quality of life. However, despite the proven benefits, only a small percentage of those would benefit from CR actually receive it worldwide. This paper by the International Council of Cardiovascular Prevention and Rehabilitation forwards the groundwork for successful CR advocacy to achieve broader reimbursement, and hence implementation. Methods: First, the results of the International Council's survey on national CR reimbursement policies by government and insurance companies are summarized. Second, a multi-faceted approach to CR advocacy is forwarded. Finally, as per the advocacy recommendations, the economic impact of CVD and the corresponding benefits of CR and its cost-effectiveness are summarized. This provides the case for CR reimbursement advocacy. Results: Thirty-one responses were received, from 25 different countries: 18 (58.1 {\%}) were from high-income countries, 10 (32.4 {\%}) from upper middle-income, and 3 (9.9 {\%}) from lower middle-income countries. When asked who reimburses at least some portion of CR services in their country, 19 (61.3 {\%}) reported the government, 17 (54.8 {\%}) reported patients pay out-of-pocket, 16 (51.6 {\%}) reported insurance companies, 12 (38.7 {\%}) reported that it is shared between the patient and another source, and 7 (22.6 {\%}) reported another source. Conclusions: Many patients pay out-of-pocket for CR. CR reimbursement around the world is inconsistent and insufficient. Advocacy campaigns forwarding the CR cause, supported by the relevant literature, enlisting sources of support in a unified manner with an organized plan, are needed, and must be pursued persistently.",
keywords = "Cardiac rehabilitation, Cardiovascular disease, Insurance, Reimbursement",
author = "Babu, {Abraham Samuel} and Francisco Lopez-Jimenez and Thomas, {Randal J.} and Wanrudee Isaranuwatchai and Herdy, {Artur Haddad} and Hoch, {Jeffrey S.} and Grace, {Sherry L.}",
year = "2016",
month = "9",
day = "6",
doi = "10.1186/s12913-016-1658-1",
language = "English (US)",
volume = "16",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Advocacy for outpatient cardiac rehabilitation globally

AU - Babu, Abraham Samuel

AU - Lopez-Jimenez, Francisco

AU - Thomas, Randal J.

AU - Isaranuwatchai, Wanrudee

AU - Herdy, Artur Haddad

AU - Hoch, Jeffrey S.

AU - Grace, Sherry L.

PY - 2016/9/6

Y1 - 2016/9/6

N2 - Background: Cardiovascular diseases (CVD) are the leading cause of death globally. Cardiac rehabilitation (CR) is an evidence-based intervention recommended for patients with CVD, to prevent recurrent events and to improve quality of life. However, despite the proven benefits, only a small percentage of those would benefit from CR actually receive it worldwide. This paper by the International Council of Cardiovascular Prevention and Rehabilitation forwards the groundwork for successful CR advocacy to achieve broader reimbursement, and hence implementation. Methods: First, the results of the International Council's survey on national CR reimbursement policies by government and insurance companies are summarized. Second, a multi-faceted approach to CR advocacy is forwarded. Finally, as per the advocacy recommendations, the economic impact of CVD and the corresponding benefits of CR and its cost-effectiveness are summarized. This provides the case for CR reimbursement advocacy. Results: Thirty-one responses were received, from 25 different countries: 18 (58.1 %) were from high-income countries, 10 (32.4 %) from upper middle-income, and 3 (9.9 %) from lower middle-income countries. When asked who reimburses at least some portion of CR services in their country, 19 (61.3 %) reported the government, 17 (54.8 %) reported patients pay out-of-pocket, 16 (51.6 %) reported insurance companies, 12 (38.7 %) reported that it is shared between the patient and another source, and 7 (22.6 %) reported another source. Conclusions: Many patients pay out-of-pocket for CR. CR reimbursement around the world is inconsistent and insufficient. Advocacy campaigns forwarding the CR cause, supported by the relevant literature, enlisting sources of support in a unified manner with an organized plan, are needed, and must be pursued persistently.

AB - Background: Cardiovascular diseases (CVD) are the leading cause of death globally. Cardiac rehabilitation (CR) is an evidence-based intervention recommended for patients with CVD, to prevent recurrent events and to improve quality of life. However, despite the proven benefits, only a small percentage of those would benefit from CR actually receive it worldwide. This paper by the International Council of Cardiovascular Prevention and Rehabilitation forwards the groundwork for successful CR advocacy to achieve broader reimbursement, and hence implementation. Methods: First, the results of the International Council's survey on national CR reimbursement policies by government and insurance companies are summarized. Second, a multi-faceted approach to CR advocacy is forwarded. Finally, as per the advocacy recommendations, the economic impact of CVD and the corresponding benefits of CR and its cost-effectiveness are summarized. This provides the case for CR reimbursement advocacy. Results: Thirty-one responses were received, from 25 different countries: 18 (58.1 %) were from high-income countries, 10 (32.4 %) from upper middle-income, and 3 (9.9 %) from lower middle-income countries. When asked who reimburses at least some portion of CR services in their country, 19 (61.3 %) reported the government, 17 (54.8 %) reported patients pay out-of-pocket, 16 (51.6 %) reported insurance companies, 12 (38.7 %) reported that it is shared between the patient and another source, and 7 (22.6 %) reported another source. Conclusions: Many patients pay out-of-pocket for CR. CR reimbursement around the world is inconsistent and insufficient. Advocacy campaigns forwarding the CR cause, supported by the relevant literature, enlisting sources of support in a unified manner with an organized plan, are needed, and must be pursued persistently.

KW - Cardiac rehabilitation

KW - Cardiovascular disease

KW - Insurance

KW - Reimbursement

UR - http://www.scopus.com/inward/record.url?scp=84986252343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986252343&partnerID=8YFLogxK

U2 - 10.1186/s12913-016-1658-1

DO - 10.1186/s12913-016-1658-1

M3 - Review article

C2 - 27600379

AN - SCOPUS:84986252343

VL - 16

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

M1 - 417

ER -